Get started
Author

Jean Jacques Garaud

Observed names: J J Garaud, J. Garaud, J. J. Garaud, J.‐J. Garaud
Institution: Inotrem (France)
Observed institution: Inotrem (France)
OpenAlex ID: A5048898485
Hepatic HCV RNA before and after treatment with interferon alone or combined with ribavirin
2002 · John G. McHutchison, Thierry Poynard, et al. · Hepatology · 115
A phase I, double-blind, placebo-controlled study of the tolerance and pharmacokinetic behaviour of RP 59500
1992 · S. D. Etienne, G. Montay, et al. · Journal of Antimicrobial Chemotherapy · 60
Predicting response to initial therapy with interferon plus ribavirin in chronic hepatitis C using serum HCV RNA results during therapy
2001 · J. G. McHutchison, J. A. Shad, et al. · Journal of Viral Hepatitis · 44
Pegylated interferon alfa-2B (PEG-intron) mono-therapy is superior to interferon alfa-2B (intron A) for the treatment of chronic hepatitis C
2000 · C. Trepo, K. Lindsay, et al. · Journal of Hepatology · 31
Moderate inhibitory effect of interleukin-10 on human neutrophil and monocyte chemotaxis in vitro.
1998 · M A Vicioso, J J Garaud, et al. · PubMed · 24
Rationale and protocol for the efficacy, safety and tolerability of nangibotide in patients with septic shock (ASTONISH) phase IIb randomised controlled trial
2021 · Bruno Francois, Simon Lambden, et al. · BMJ Open · 21
PDF
The role of interleukin-10 in severe acute alcoholic hepatitis
2001 · Julien Taı̈eb, Sylvie Chollet-Martin, et al. · Clinical Biochemistry · 9
Clinical development of interleukin-10.
1997 · A Lebeaut, J J Garaud · PubMed · 7
Identification of the biomarker soluble TREM-1 as a candidate for a personalised medicine approach for nangibotide treatment of septic shock
2022 · Simon Lambden, Jean-Marie Grouin, et al. · Research Square · 1
PDF
Sepsis 2016 Paris : Paris, France. 6-8 December 2016
2016 · Marcia Ingles, Gary Crowfoot, et al. · Europe PMC (PubMed Central)
Works count: 10
Citation count: 312
H-index: 7
I10-index: 6
Year
Topic
Type